((自动化翻译由路透提供，请见免责声明 ))
12月4日 - ** 美国制药商礼来 的股价在收盘前上涨2%至829.84美元
** 礼来称其 减肥药Zepbound帮助患者平均减重20.2%，而诺和诺德 的Wegovy减重13.7
** 在美国上市的诺和诺德 股价下跌约1%，报收于108.56美元。 盘前
** LLY称Zepbound在 试验 的所有 五个关键次要目标上都 优于Wegovy
** 公司将继续评估试验结果，并计划在明年的医学会议上公布这些结果
** 截至上次收盘，LLY上涨了39.5%，诺和诺德在美国上市的股票今年上涨了7%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.